Studies | C1 | C2 | C3 | C4 | C5 | % subjects proceeding to surgery | No serious adverse events reported |
---|---|---|---|---|---|---|---|
Aksac (2003) | Â | 1 | 1 | 1 | Â | Â | Â |
Arvonen (2001) | 1 | 1 | 1 | Â | Â | Â | Â |
Balmforth (2004) | 1 | 1 | Â | 2 | Â | Â | Â |
Berghmans (1996) | 1 | 2 | 1 | 1 | Â | Â | Â |
Bidmead (2002) | 1 | 1 | Â | 1 | Â | Â | Â |
Bo (1999) | 3 | 3 | 1 | 1 | Â | Â | yes |
Bo (2000) | Â | Â | Â | 1 | Â | Â | Â |
Cammu & van Nylen (1998) | 2 | 3 | 1 | 1 | Â | 17 | yes |
Chen (1999) | Â | 2 | 1 | Â | Â | Â | yes |
Dumoulin (1995) | 1 | 1 | 1 | Â | Â | Â | Â |
Dumoulin (2004) | 1 | 1 | 1 | 2 | Â | Â | yes |
Finkenhagen (1998) | 1 | Â | Â | Â | Â | Â | Â |
Glavind (1996) | 1 | 1 | Â | Â | Â | Â | yes |
Hay-Smith (2002) | 1 | 2 | Â | Â | Â | Â | Â |
Johnson (2001) | 1 | 2 | 1 | Â | Â | Â | Â |
Knight (1998) | 1 | 1 | 1 | Â | Â | Â | Â |
Miller (1998) | Â | 1 | Â | Â | Â | Â | Â |
Morkved (2002) | 2 | 2 | 1 | 1 |  | 4.3–6.3 | yes |
Pages (2001) | 1 | Â | 1 | Â | Â | Â | Â |
Parkkinen (2004) | 1 | 1 | 1 | Â | Â | 10.5 | yes |
Pieber (1995) | 1 | Â | Â | Â | Â | 0 | Â |
Sung (2000) | 1 | Â | Â | Â | Â | Â | Â |
Turkan (2005) | 1 | 3 | 1 | Â | Â | Â | Â |
Wong (2001) | 1 | 2 | 1 | 1 | Â | Â | Â |